Advertisement

Topics

FDA grants rare pediatric disease status to Albireo's liver disease drug

06:27 EDT 13 Jun 2018 | SmartBrief

Albireo Pharma's late-stage candidate A4250 was given rare pediatric disease status by the FDA.  -More

Original Article: FDA grants rare pediatric disease status to Albireo's liver disease drug

NEXT ARTICLE

More From BioPortfolio on "FDA grants rare pediatric disease status to Albireo's liver disease drug"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Pediatrics
Pediatrics is the general medicine of childhood. Because of the developmental processes (psychological and physical) of childhood, the involvement of parents, and the social management of conditions at home and at school, pediatrics is a specialty. With ...

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...